Neptune Retains Stifel to Explore Strategic Alternatives for Sprout Organics

5 months ago

LAVAL, QC / ACCESSWIRE / January 24, 2024 / Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT), a consumer-packaged…

Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024

5 months ago

AUSTIN, TX / ACCESSWIRE / January 24, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology…

Modular Medical Announces Issuance of New US Patent

5 months ago

SAN DIEGO, CA / ACCESSWIRE / January 24, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a…

Pima Heart & Vascular Hosts Leading Cardiology Conference in Tucson This February

5 months ago

TUCSON, AZ / ACCESSWIRE / January 24, 2024 / Pima Heart & Vascular proudly announces its leadership role in hosting…

Pain treatment with Dr Allen’s Device is proven in people with low back pain, chronic prostatitis and kidney stones

5 months ago

* New clinical trials have confirmed that Thermobalancing therapy with Dr Allen's Device is the first natural treatment option for…

PHBI – Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its’ Nutraceutical Formulations

5 months ago

CARSON CITY, NV / ACCESSWIRE / January 24, 2024 / Pharmagreen Biotech, Inc., (OTC PINK:PHBI), "Pharmagreen" or the "Company" is…

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

5 months ago

HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altamira’s polyKRASmut siRNA shown to knock down at least 65-91% of KRAS…

Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products

5 months ago

LOS ANGELES, CA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix Biopharma”, “Company”, “We” or “Us”, Nasdaq:IMMX), a…

Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets

5 months ago

Tailored Vaccines: With the AI-Immunology™ enabled discovery of these novel types of cancer vaccine targets, designing personalized and precision vaccine…

nmible partners with Velocity Clinical Research to streamline clinical trials patient stipends

5 months ago

Velocity President and Chief Executive, Dr Paul Evans Velocity President and Chief Executive, Dr Paul Evans •  nmible’s solution expected…